Breast Carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
Our results suggested that rs895819 polymorphism was correlated with increased risk of colorectal cancer and breast cancer, but not all types of cancer.
|
31838252 |
2020 |
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Our results suggested that rs895819 polymorphism was correlated with increased risk of colorectal cancer and breast cancer, but not all types of cancer.
|
31838252 |
2020 |
Colorectal Carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
Our results suggested that rs895819 polymorphism was correlated with increased risk of colorectal cancer and breast cancer, but not all types of cancer.
|
31838252 |
2020 |
Malignant neoplasm of breast
|
|
0.100 |
GeneticVariation
|
BEFREE |
Our results suggested that rs895819 polymorphism was correlated with increased risk of colorectal cancer and breast cancer, but not all types of cancer.
|
31838252 |
2020 |
Primary malignant neoplasm
|
|
0.100 |
GeneticVariation
|
BEFREE |
Our results suggested that rs895819 polymorphism was correlated with increased risk of colorectal cancer and breast cancer, but not all types of cancer.
|
31838252 |
2020 |
Breast Carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
Conclusion Our data indicate that miR-146a (rs2910164) and miR-27a (rs895819) variants contribute to breast cancer.
|
29521182 |
2018 |
Malignant neoplasm of breast
|
|
0.100 |
GeneticVariation
|
BEFREE |
The present study indicates that only the rs895819 polymorphism was associated with BC risk.
|
29782194 |
2018 |
Breast Carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
The present study indicates that only the rs895819 polymorphism was associated with BC risk.
|
29782194 |
2018 |
Colorectal Carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
On the other hand, rs895819 (miR-27a) GG carriers were more susceptible to CRC (OR = 1.47, 95% CI = 1.21-1.78, P = <0.05) in a recessive genetic model.
|
30447914 |
2018 |
Malignant neoplasm of breast
|
|
0.100 |
GeneticVariation
|
BEFREE |
Conclusion Our data indicate that miR-146a (rs2910164) and miR-27a (rs895819) variants contribute to breast cancer.
|
29521182 |
2018 |
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Furthermore, stratification analyses revealed an association of rs895819</span> with increased cancer risk among Asians (GG <i>vs.</i> AA: OR = 1.17, 95% CI = 1.01-1.36; GG <i>vs.</i> AA/AG: OR = 1.18, 95% CI = 1.03-1.35), but not Caucasians.
|
29088869 |
2017 |
Primary malignant neoplasm
|
|
0.100 |
GeneticVariation
|
BEFREE |
Furthermore, stratification analyses revealed an association of rs895819</span> with increased cancer risk among Asians (GG <i>vs.</i> AA: OR = 1.17, 95% CI = 1.01-1.36; GG <i>vs.</i> AA/AG: OR = 1.18, 95% CI = 1.03-1.35), but not Caucasians.
|
29088869 |
2017 |
Colorectal Carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
To summarize, our results indicated that rs895819 was a protective factor for cancer in Caucasians and could increase colorectal cancer risk but decrease breast cancer risk.
|
28415619 |
2017 |
Breast Carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
C allele in the variant rs895819 is associated with decreased risk of breast cancer.
|
29128203 |
2017 |
Primary malignant neoplasm
|
|
0.100 |
GeneticVariation
|
BEFREE |
To summarize, our results indicated that rs895819 was a protective factor for cancer in Caucasians and could increase colorectal cancer risk but decrease breast cancer risk.
|
28415619 |
2017 |
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
To summarize, our results indicated that rs895819 was a protective factor for cancer in Caucasians and could increase colorectal cancer risk but decrease breast cancer risk.
|
28415619 |
2017 |
Malignant Neoplasms
|
|
0.100 |
GeneticVariation
|
BEFREE |
A meta-analysis was conducted to provide evidence for the effect of microRNA 27a rs895819 on cancer survival.
|
29100439 |
2017 |
Primary malignant neoplasm
|
|
0.100 |
GeneticVariation
|
BEFREE |
A meta-analysis was conducted to provide evidence for the effect of microRNA 27a rs895819 on cancer survival.
|
29100439 |
2017 |
Colorectal Carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
However, rs895819 was associated with increased risk of colorectal cancer (GG <i>vs.</i> AA: OR = 1.56, 95% CI = 1.31-1.85; GG <i>vs.</i> AA/AG: OR = 1.53, 95% CI = 1.30-1.79; G <i>vs.</i> A: OR = 1.19, 95% CI = 1.09-1.30) and lung cancer (GG <i>vs.</i> AA/AG: OR = 1.43, 95% CI = 1.00-2.04).
|
29088869 |
2017 |
Malignant neoplasm of breast
|
|
0.100 |
GeneticVariation
|
BEFREE |
C allele in the variant rs895819 is associated with decreased risk of breast cancer.
|
29128203 |
2017 |
Malignant neoplasm of breast
|
|
0.100 |
GeneticVariation
|
BEFREE |
Interestingly, the [G] allele of rs895819 was significantly associated with decreased risk of breast cancer (G <i>vs.</i> A: OR = 0.91, 95% CI = 0.86-0.97).
|
29088869 |
2017 |
Breast Carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
To summarize, our results indicated that rs895819 was a protective factor for cancer in Caucasians and could increase colorectal cancer risk but decrease breast cancer risk.
|
28415619 |
2017 |
Breast Carcinoma
|
|
0.100 |
GeneticVariation
|
BEFREE |
Interestingly, the [G] allele of rs895819 was significantly associated with decreased risk of breast cancer (G <i>vs.</i> A: OR = 0.91, 95% CI = 0.86-0.97).
|
29088869 |
2017 |
Malignant neoplasm of breast
|
|
0.100 |
GeneticVariation
|
BEFREE |
To summarize, our results indicated that rs895819 was a protective factor for cancer in Caucasians and could increase colorectal cancer risk but decrease breast cancer risk.
|
28415619 |
2017 |
Malignant neoplasm of breast
|
|
0.100 |
GeneticVariation
|
BEFREE |
In conclusion, the rs2292832 polymorphism was significantly associated with increased breast cancer</span> risk, and the rs895819 polymorphism contributes to the susceptibility of colorectal and breast cancer.
|
26993779 |
2016 |